Skip to main content
. 2018 Feb 21;7(3):149–154. doi: 10.1159/000487234

Table 3.

Oncological outcome

Response to therapy 6–12 months after RAI (n = 42) % End of follow-up (n = 42) %
Excellent response 24 57 27 64
Indeterminate response 8 19 8 19
Biochemical incomplete response 2 5 1 2.5
Structural incomplete response 3 7 1 2.5
Not yet available 2 5 2 5
Lost to follow-up 3 7 3 7

Median duration of follow-up, months last follow-up (n = 15) 15.9 (5–62)

Response to therapy according to ATA 2015 guidelines [2]. ATA, American Thyroid Association; RAI, radioiodine.